Literature DB >> 15098063

NF-kappaB and reperfusion injury.

Timothy C Nichols1.   

Abstract

This review discusses the current understanding of mechanisms that mediate activation of the transcription factor nuclear factor-kappaB (NF-kappaB) and how such activation could in turn mediate reperfusion injury. NF-kappaB regulates the expression of several genes involved in inflammation, the immune response, apoptosis, cell survival and proliferation. Many of these same genes are activated during reperfusion injury. The rationale for considering inhibiting NF-kappaB activation as a promising molecular target for ameliorating reperfusion injury in the brain during stroke, the heart during myocardial infarction and the intestines following prolonged ischemia is discussed on the basis of a new understanding of the mechanisms by which NF-kappaB is activated. A complete anthology of the reperfusion injury literature is beyond the scope of this article and the authors apologize to any investigator not cited for their contributions. (c) 2004 Prous Science. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15098063     DOI: 10.1358/dnp.2004.17.2.829042

Source DB:  PubMed          Journal:  Drug News Perspect        ISSN: 0214-0934


  35 in total

Review 1.  Soluble epoxide hydrolase inhibitors and heart failure.

Authors:  Hong Qiu; Ning Li; Jun-Yan Liu; Todd R Harris; Bruce D Hammock; Nipavan Chiamvimonvat
Journal:  Cardiovasc Ther       Date:  2011-04       Impact factor: 3.023

Review 2.  Mesenchymal stromal cell therapy for the treatment of intestinal ischemia: Defining the optimal cell isolate for maximum therapeutic benefit.

Authors:  Dominique L Doster; Amanda R Jensen; Sina Khaneki; Troy A Markel
Journal:  Cytotherapy       Date:  2016-10-10       Impact factor: 5.414

3.  Human colonic myocytes are involved in postischemic inflammation through ADAM17-dependent TNFalpha production.

Authors:  Anne Jarry; Kalyane Bach-Ngohou; Damien Masson; Thomas Dejoie; Paul-Antoine Lehur; Jean-François Mosnier; Marc G Denis; Christian L Laboisse
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

4.  Adenosine postconditioning protects against myocardial ischemia-reperfusion injury though modulate production of TNF-α and prevents activation of transcription factor NF-kappaB.

Authors:  Jian-Juan Ke; Feng-Xu Yu; Yan Rao; Yan-Lin Wang
Journal:  Mol Biol Rep       Date:  2010-04-09       Impact factor: 2.316

5.  Intracellular mechanisms of N-acylethanolamine-mediated neuroprotection in a rat model of stroke.

Authors:  P Garg; R S Duncan; S Kaja; P Koulen
Journal:  Neuroscience       Date:  2009-12-03       Impact factor: 3.590

6.  Somatostatin limits intestinal ischemia-reperfusion injury in macaques via suppression of TLR4-NF-kappaB cytokine pathway.

Authors:  Hao Wu; Ling Liu; Qinghua Tan; Chunhui Wang; Meimei Guo; Yongmei Xie; Chengwei Tang
Journal:  J Gastrointest Surg       Date:  2009-01-29       Impact factor: 3.452

Review 7.  Myocardial repair/remodelling following infarction: roles of local factors.

Authors:  Yao Sun
Journal:  Cardiovasc Res       Date:  2008-12-02       Impact factor: 10.787

8.  Modification of oxidative stress on gene expression profiling in the rat infarcted heart.

Authors:  Wenyuan Zhao; Tieqiang Zhao; Yuanjian Chen; Yanhua Qu; Ivan C Gerling; Yao Sun
Journal:  Mol Cell Biochem       Date:  2013-04-06       Impact factor: 3.396

9.  Parthenolide-Induced Cytotoxicity in H9c2 Cardiomyoblasts Involves Oxidative Stress.

Authors:  Tien-Yao Tsai; Paul Chan; Chi-Li Gong; Kar-Lok Wong; Tzu-Hui Su; Pei-Chen Shen; Yuk-Man Leung; Zhong-Min Liu
Journal:  Acta Cardiol Sin       Date:  2015-01       Impact factor: 2.672

10.  Insulin reduces cerebral ischemia/reperfusion injury in the hippocampus of diabetic rats: a role for glycogen synthase kinase-3beta.

Authors:  Massimo Collino; Manuela Aragno; Sara Castiglia; Chiara Tomasinelli; Christoph Thiemermann; Giuseppe Boccuzzi; Roberto Fantozzi
Journal:  Diabetes       Date:  2008-10-07       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.